Nova Pneuma Inc. ("NPI"), the Delaware incorporated and wholly owned subsidiary of Lee's Pharmaceutical Holdings Limited ...
Pharmaceutical Technology on MSN
Mirum to buy Bluejay for up to $820m in rare liver disease push
The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.
The biannual AustinPx Amorphous Solid Dispersions (ASD) Workshop is a place for collaboration and innovation. Hear firsthand ...
Pharmaceutical Technology on MSN
Inductive Bio gains $21m ARPA-H funds for drug prediction models
Inductive Bio has secured up to $21m in funding from ARPA-H to lead the development of AI drug-toxicity prediction models.
Pharmaceutical Technology on MSN
Pfizer gains another obesity asset with $2bn deal for YaoPharma’s GLP-1RA
This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.
Software solutions today are equally important, as they enable integration of disparate automated unit operations with data ...
First and Only AI-Simulated Roleplay Solution Exclusively Designed for Pharmaceutical Field Professionals, Awarded for AI Roleplay and Field Simulation Excellence ...
South Korea will require advertisers to label their ads made with artificial intelligence technologies from next year as it ...
Nearly one in four European pharmaceutical companies remains vulnerable to regulatory risks due to inadequate quality systems ...
GS Equity Income Fund underperformed in Q3. Discover key contributors like Oracle & J&J, and detractors Kenvue & Honeywell.
Stocktwits on MSN
Gelteq preclinical study demonstrates enhanced oral delivery of oil-soluble and poorly soluble drugs using its gel-based platform
Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery ...
The discovery, featured on the cover of Analytical Chemistry, could potentially slow the progression to full-blown diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results